CiaranPKellyMD
Gastroenterology • Boston, MAProfessor of Medicine, Beth Israel Deaconess Medical Center
Are you Dr. Kelly?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 32 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Bideaconess Medical Ctr
330 Brookline Avenue
Boston, MA 02215Phone+1 617-667-1272Fax+1 617-667-5826
Summary
- Dr. Ciaran Kelly, MD is a gastroenterologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts, New Hampshire, and Florida. He is affiliated with Beth Israel Deaconess Medical Center and is a Professor of Medicine at Beth Israel Deaconess Medical Center.
Education & Training
University of Dublin Trinity CollegeClass of 1982
Certifications & Licensure
MA State Medical License 1991 - 2025
NH State Medical License 2024 - 2024
FL State Medical License 2013 - 2017- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (AGAF) American Gastroenterological Association, 2009
Clinical Trials
- Serum Markers in Gluten Challenge Start of enrollment: 2009 Apr 01
- Effects of Pre-, Pro- & Anti-biotics on Gut Microbiota Start of enrollment: 2011 Aug 01
- Effects of S. Boulardii and Amoxicillin/Clavulanate on Gut Microbiota Start of enrollment: 2012 Apr 01
Publications & Presentations
PubMed
- Ulcerative Jejunitis in Celiac Disease: A Thirty-Year U.S. Experience.Yevgen Chornenkyy, Masa Peric, David Marin Flores, Yuho Ono, Shweta A Shinagare
The American Journal of Gastroenterology. 2024-10-30 - Understanding host immune responses ininfection: Implications for pathogenesis and immunotherapy.Lamei Wang, Javier A Villafuerte Gálvez, Christina Lee, Shengru Wu, Ciaran P Kelly
Imeta. 2024-06-01 - 1 citationsBudesonide, an anti-inflammatory drug, exacerbate clostridioides difficile colitis in mice.Qianyun Lin, Zitong Li, Lei Lu, Hua Xu, Eddie Lou
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 2023-11-01
Press Mentions
Separating Fact from Fallacy in Celiac DiseaseAugust 25th, 2021
Potential Nanotechnology Treatment for Celiac Disease RevealedOctober 25th, 2019
Celiac Disease: New Treatment Shows Promise in TrialOctober 24th, 2019- Join now to see all
Grant Support
- Combination Clostridium Difficile Toxin And Adhesin VaccineNational Institute Of Allergy And Infectious Diseases2011
- Research Training In GastroenterologyNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
- Mechanisms For The Intestinal Probiotic Effects Of S. BoulardiiNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2009
- Immune Response To Clostridium DifficileNational Institute Of Allergy And Infectious Diseases2004–2008
- Correlates Of Gluten-Free Diet Compliance In Adults With Celiac DiseaseNational Center For Research Resources2007
- Gluten Free Diet Adherence StudyNational Center For Research Resources2006
- Mechanisms Of Leukocyte Recruitment In IBDNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2005
- Pathogenic Mechanisms Of Helicobacter Pylori GastritisNational Institute Of Diabetes And Digestive And Kidney Diseases1998–2002
- Survival Of Oral Bic-C Difficile In Volunteers With An IleostomyNational Center For Research Resources1997–1999
- Cell Adhesion Molecule Upregulation In IBDNational Institute Of Diabetes And Digestive And Kidney Diseases1995–1997
- Cell Adhesion Molecule Upregulation In IBDNational Institute Of Diabetes And Digestive And Kidney Diseases1995
- Cell Adhesion Molecule Upregulation In IboNational Institute Of Diabetes And Digestive And Kidney Diseases1993–1994
Professional Memberships
- Fellow
